Montse Llinàs‐Brunet

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Daniel Lamarre, Paul C. Anderson, Murray D. Bailey et al. · Nature · 2003 · 911 citations

Antiviral Effects, Hepatology, Hepatitis C Virus +9

Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection

Youla S. Tsantrizos, Gordon T. Bolger, Pierre Bonneau et al. · Angewandte Chemie International Edition · 2003 · 188 citations

Immunology, Nmr-derived Conformation, Antiviral Drug +17

Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061

Montse Llinàs‐Brunet, Murray D. Bailey, Gordon T. Bolger et al. · Journal of Medicinal Chemistry · 2004 · 186 citations

Competitive Hexapeptide Inhibitors, Pharmacotherapy, Antiviral Drug +16

Peptide-based inhibitors of the hepatitis C virus serine protease

Montse Llinàs‐Brunet, Murray D. Bailey, Gulrez Fazal et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 162 citations · Full text

Biochemistry, Natural Sciences, Antiviral Drug Development +7

A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease:  Discovery of Potent and Specific Tripeptide Inhibitors

Montse Llinàs‐Brunet, Murray D. Bailey, Élise Ghiro et al. · Journal of Medicinal Chemistry · 2004 · 122 citations · Full text

Peptide Substrates, Antiviral Drug, Chemical Biology +21